Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis

Cheung, BB; Mittra, R; Murray, J; Wang, Q; Seneviratne, JA; Raipuria, M; Wong, IPL; Restuccia, D; Gifford, A; Salib, A; Sutton, S; Huang, L; Ferdowsi, PV; Tsang, J; Sekyere, E; Mayoh, C; Luo, L; Brown, DL; Stow, JL; Zhu, S; Young, RJ; Solomon, BJ; Chappaz, S; Kile, B; Kueh, A; Herold, MJ; Hilton, DJ; Liu, T; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM

Author(s): Cheung, BB; Mittra, R; Murray, J; Wang, Q; Seneviratne, JA; Raipuria, M; Wong, IPL; Restuccia, D; Gifford, A; Salib, A; Sutton, S; Huang, L; Ferdowsi, PV; Tsang, J; Sekyere, E; Mayoh, C; Luo, L; Brown, DL; Stow, JL; Zhu, S; Young, RJ; Solomon, BJ; Chappaz, S; Kile, B; Kueh, A; Herold, MJ; Hilton, DJ; Liu, T; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM;
Details: Publication Year 2024-10-14,Volume 7,Issue #1,Page 1322
Journal Title: Communications Biology
Abstract: MYCN amplification predicts poor prognosis in childhood neuroblastoma. To identify MYCN oncogenic signal dependencies we performed N-ethyl-N-nitrosourea (ENU) mutagenesis on the germline of neuroblastoma-prone TH-MYCN transgenic mice to generate founders which had lost tumorigenesis. Sequencing of the mutant mouse genomes identified the Ring Finger Protein 121 (RNF121(WT)) gene mutated to RNF(M158R) associated with heritable loss of tumorigenicity. While the RNF121(WT) protein localised predominantly to the cis-Golgi Complex, the RNF121(M158R) mutation in Helix 4 of its transmembrane domain caused reduced RNF121 protein stability and absent Golgi localisation. RNF121(WT) expression markedly increased during TH-MYCN tumorigenesis, whereas hemizygous RNF121(WT) gene deletion reduced TH-MYCN tumorigenicity. The RNF121(WT)-enhanced growth of MYCN-amplified neuroblastoma cells depended on RNF121(WT) transmembrane Helix 5. RNF121(WT) directly bound MYCN protein and enhanced its stability. High RNF121 mRNA expression associated with poor prognosis in human neuroblastoma tissues and another MYC-driven malignancy, laryngeal cancer. RNF121 is thus an essential oncogenic cofactor for MYCN and a target for drug development.
Publisher: Springer Nature
Keywords: *Neuroblastoma/genetics/metabolism/pathology; *N-Myc Proto-Oncogene Protein/genetics/metabolism; Animals; Mice; Humans; Carcinogenesis/genetics; Golgi Apparatus/metabolism; Mice, Transgenic; Cell Line, Tumor; Gene Expression Regulation, Neoplastic
Research Division(s): Epigenetics And Development; Blood Cells And Blood Cancer
PubMed ID: 39402275
Publisher's Version: https://doi.org/10.1038/s42003-024-06899-8
Open Access at Publisher's Site: https://doi.org/10.1038/s42003-024-06899-8
Terms of Use/Rights Notice: Refer to copyright notice on published article.
Documents: s42003-024-06899-8.pdf - (2.78MB, application/pdf)

Creation Date: 2024-10-25 10:15:29

Last Modified: 2024-10-25 10:18:51